Clinical Trial

Taper Or Abrupt Steroid Stop: TOASSTtrial

Name: Taper Or Abrupt Steroid Stop: TOASSTtrial — clinical trial record (NCT03153527)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TOASST

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study is an Investigator-initiated, placebo-controlled, multicenter noninferiority trial, comparing rapid termination of systemic glucocorticoid treatment with a tapering regime over 4 weeks.

Protocol Amendment History 15 amendments

This ClinicalTrials.gov record has been amended 15 times since 2017-05-11; most recent amendment 2026-04-20.

Trial Details

NCT Number	NCT03153527
Lead Sponsor	University Hospital, Basel, Switzerland Collaborators: Kantonsspital Baselland Bruderholz, Swiss National Science Foundation, HEMMI Stiftung Switzerland, Gebauer Stiftung Zurich
Conditions	Inflammatory Disorder, Autoimmune
Enrollment	530 participants
Start Date	2017-05-31
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-04-22